Following years of comprehensive clinical practice in India, Dr. Kodishala transitioned to global clinical research. He joined the Division of Rheumatology at the Mayo Clinic as a post-doctoral research fellow.
Currently, Dr. Kodishala is an , where he continues to apply his research insights to direct patient care.
In recent years, there has been a renewed interest in reviving the spirit of Chanakya Kodishala. Efforts have been made to recreate the institution in a modern avatar, with a focus on interdisciplinary research, academic excellence, and community engagement. These initiatives aim to rekindle the flame of intellectual curiosity and critical thinking that once burned brightly at Chanakya Kodishala.
A: Due to the privacy of the fintech industry, specific employer names are often under non-disclosure agreements (NDAs). However, his expertise spans multiple Series-B and Series-C funded fintech startups based out of Bengaluru and Hyderabad. Chanakya Kodishala
Critics call this naive. Data without a party machine is useless. But Kodishala is betting on the fragmentation of Indian politics. “The era of the wave election is over,” he predicts. “The next decade is about 543 micro-elections. The candidate who knows her ward better than the DM wins.”
In the popular imagination, political strategists are either backroom deal-makers in rumpled suits or fire-breathing ideologues on news debates. Rarely do they resemble Chanakya Kodishala. Soft-spoken, armed with a laptop running Python scripts, and more comfortable discussing p-values than punchlines, Kodishala represents a new breed of political operative: the data scientist as kingmaker.
—specifically how non-joint-related conditions affect patients with autoimmune rheumatic diseases. Following years of comprehensive clinical practice in India,
Dr. Kodishala has co-authored a multitude of peer-reviewed articles and clinical trial findings. His major scientific focus areas include: 1. Rheumatoid Arthritis and Cognitive Decline
As Dr. Kodishala continues his residency training, he stands at an exciting crossroads. His unique background as both a clinical rheumatologist and a research fellow with a specific focus on neuroimmunology positions him to make even more significant contributions in the future.
In the rapidly evolving field of rheumatology, clinical research plays a pivotal role in bridging the gap between molecular mechanisms and patient outcomes. , has emerged as a significant contributor to this field, particularly in the areas of systemic autoimmune diseases, their comorbidities, and the impact of systemic inflammation on long-term health, such as dementia risk. Currently, Dr
Share recent findings on the link between Rheumatoid Arthritis and Dementia.
The research demonstrates that systemic inflammation doesn't just damage cartilage; it drives accelerated atherosclerosis and blood-vessel degradation.
Involved in research regarding autoimmune disease management. Conclusion
: Continuing his clinical path in the United States, he later joined the Canton Medical Education Foundation in Canton, Ohio, as an Internal Medicine resident to align his global expertise with American direct-patient care systems. Key Research Focus Areas
Chanakya Kodishala, MBBS, DM, is a prominent rheumatologist and researcher whose work has significantly advanced our understanding of systemic autoimmune diseases and their complex comorbidities. Currently affiliated with the Mayo Clinic's Division of Rheumatology , Kodishala has authored numerous high-impact studies focusing on the intersection of inflammatory conditions and long-term health risks like dementia and cardiovascular disease. Research Focus: The RA-Dementia Connection